TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 2,727,943 | 2,501,945 | 1,910,230 |
Financial expenses | 11,016 | 11,167 | 11,426 |
Earnings before taxes | 167,702 | 174,721 | 96,813 |
EBITDA | 179,848 | 187,333 | 110,149 |
Total assets | 902,489 | 821,604 | 549,082 |
Current assets | 884,714 | 803,737 | 531,130 |
Current liabilities | 324,567 | 368,388 | 226,384 |
Equity capital | 443,322 | 318,616 | 188,098 |
- share capital | 100 | 100 | 100 |
Employees (average) | 21 | 21 | 20 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 49.1% | 38.8% | 34.3% |
Turnover per employee | 129,902 | 119,140 | 95,512 |
Profit as a percentage of turnover | 6.1% | 7.0% | 5.1% |
Return on assets (ROA) | 19.8% | 22.6% | 19.7% |
Current ratio | 272.6% | 218.2% | 234.6% |
Return on equity (ROE) | 37.8% | 54.8% | 51.5% |
Change turnover | 225,998 | 591,715 | -107,422 |
Change turnover % | 9% | 31% | -5% |
Chg. No. of employees | 0 | 1 | 2 |
Chg. No. of employees % | 0% | 5% | 11% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.